VERA
Vera Therapeutics, Inc. Class A · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website veratx.com
- Employees(FY) 49
- ISIN US92337R1014
Performance
-2.22%
1W
-2.77%
1M
-9.94%
3M
+213.09%
6M
+169.12%
YTD
+445.32%
1Y
Profile
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy; and for treatment of lupus nephritis. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.
Investment Analysis Report: VERA
Overview
VERA is a company operating in the Health Technology sector, specifically in the Biotechnology industry. The company has shown significant growth in its financial metrics over the past three years, with an increasing market capitalization and total assets. In this report, we will conduct a comprehensive ...
Technical Analysis of VERA 2024-05-10
Overview:
In analyzing the provided VERA TA data for the last 5 days, we will delve into the technical indicators across trend, momentum, volatility, and volume to derive insights into the possible future stock price movement. By examining these indicators comprehensively, we aim to provide a well-informed prediction backed by data-driven analys...
Recent News & Updates
- 2024-05-17 16:27
- 2024-05-10 05:38
- 2024-05-09 08:00
- 2024-05-09 01:53
- 2024-05-08 20:00
- 2024-05-07 16:38
- 2024-05-07 04:38
- 2024-05-06 08:38
- 2024-04-23 17:09
Health Care Roundup: Market Talk(The Wall Street Journal)
- 2024-04-13 05:29
Could This Stock Be the Next Biotech Buyout?(Motley Fool)
- 2024-04-12 19:01
- 2024-04-11 16:29
Vertex Pharmaceuticals to buy Alpine Immune Sciences in $4.9B deal(Yahoo Finance Video)
- 2024-04-05 18:30
- 2024-04-02 08:00
- 2024-04-01 20:00
- 2024-03-20 07:30
- 2024-03-20 00:52
- 2024-03-19 19:30
- 2024-02-28 16:20
- 2024-02-28 03:20
- 2024-02-11 08:23
Estimating The Fair Value Of Vera Therapeutics, Inc. (NASDAQ:VERA)(Simply Wall St.)
- 2024-02-02 08:00
- 2024-02-01 23:40
- 2024-02-01 19:00
- 2024-02-01 16:05
- 2024-01-29 23:50
- 2024-01-29 06:15
- 2024-01-25 06:30
- 2024-01-24 17:30
- 2024-01-12 18:44
Why Vera Therapeutics Stock Soared by 22% This Week(Motley Fool)
Page 1 of 5
previousnext